News

The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...
According to the Financial Times, MSD – known as Merck & Co in the US and Canada – is in the final stages of a $10 billion ...
Merck, through a subsidiary, will acquire Verona Pharma for a total transaction value of approximately $10 billion.
British American Tobacco ( NYSE: BTI) was noted to have a strong balance sheet and rich cash returns, while room for improvement with margins is seen. In terms of valuation, British American Tobacco ( ...
Silver Bullet Mines Corp. (TSXV: SBMI) (OTCQB: SBMCF) ('SBMI' or 'the Company') is pleased to announce it has signed back a ...
Olorofim, a novel antifungal agent, shows efficacy and tolerability in patients with invasive fungal diseases with limited ...
Merck & Co., Inc. (NYSE:MRK) ranks among the best set-it-and-forget-it stocks to buy. On June 27, TD Cowen maintained its ...
One of the biggest patent cliffs is set to hit the pharmaceutical industry this decade, with major players bracing for a blow ...
US pharma giant seeks to expand footprint beyond cancer treatment as its biggest product nears patent cliff ...
Details such as clean streets and nice landscaping have lured office tenants by offering the perks of downtown without the ...